Recently, the Ministry of Commerce issued the "Report on the Analysis of the Distribution of Key Chinese Medicinal Materials in 2011". The first batch of 29 key species of commonly used Chinese herbal medicines were selected, 104 origins of Chinese herbal medicines, 13 professional markets of Chinese medicinal materials, and 6 professional websites of Chinese medicinal materials were selected. The statistical analysis was conducted on the planting area, harvested area, yield, origin price, sales volume, inventory, and sales price of Chinese herbal medicines.
The "Report" pointed out that in response to the anomalous fluctuations in prices of Chinese herbal medicines and asymmetric production and sales information in recent years, according to the requirements of the National Drug Distribution Industry Development Outline (2011-2015), in 2012, the Ministry of Commerce established key varieties of Chinese herbal medicines. The circulation analysis system provides the government and industry with basic information on the circulation of Chinese herbal medicines and promotes the healthy development of the Chinese herbal medicine industry.
The publication of the "Report" has changed the situation of the lack of authoritative statistical information on the circulation of Chinese herbal medicines for a long time. It is of great significance to maintain the basic stability of Chinese herbal medicines, effectively guide production and sales, and formulate policies for the development of Chinese herbal medicine industry.
According to the progress of this work, the Ministry of Commerce will gradually increase statistical varieties and expand market coverage so that circulation analysis of key varieties of Chinese herbal medicines can fully reflect the dynamics of Chinese herbal medicines circulation.
Analysis report on the circulation of some key varieties of Chinese herbal medicines in 2011 The Chinese herbal medicines are the basis of the Chinese medicine industry. The circulation of Chinese herbal medicines is an important part of the circulation of medicines. In response to the anomalous fluctuations in prices of Chinese herbal medicines and asymmetric production and sales information in recent years, according to the National Outline for the Development of Drug Distribution Industry (2011-2015), in 2012, the Ministry of Commerce established a circulation analysis system for key varieties of Chinese herbal medicines. Providing basic information on the circulation of Chinese herbal medicines for the government and industry, and promoting the healthy development of the Chinese herbal medicine industry.Analysis of basic market information such as cultivation, price, sales, and inventory of some key varieties of Chinese herbal medicines in 2011 has been completed, and the results are reported below.
I. The statistical varieties of key varieties of Chinese herbal medicines and circulation analysis data for the circulation analysis of key varieties of Chinese herbal medicines are gradually developed in stages. The first statistical analysis of 29 kinds of Chinese medicinal materials are: ginseng, Panax notoginseng, Rhizoma Chuanxiong, rhubarb, yam, hawthorn, milk thistle, heterophylla, Yuanhu, Salvia, gastrodia, Pinellia, Angelica, licorice, rehmannia root, angelica, wheat Winter, forsythia, moutan, aconite, honeysuckle, Chinese wolfberry, Magnolia officinalis, Poria, Codonopsis, Coptis, Astragalus, Astragalus, pilose antler. In the future, based on the progress of this work, we will gradually increase the statistical analysis of varieties, so that the circulation analysis system of key varieties of Chinese herbal medicines can reflect the situation of the entire industry as far as possible.
The statistical data of planting area and production of 29 kinds of Chinese herbal medicines come from the business and agriculture and forestry departments of 104 Chinese herbal medicine producing areas; the market circulation of Chinese herbal medicines comes from 13 professional markets of Chinese medicinal materials (see Table 3 in the attached list); there are 6 Chinese herbs The professional web site (listed in Schedule 4) participated in the supplementary reporting of relevant data.
II. Price of planting and producing areas of 29 key Chinese herbal medicines in 2011 The planting area, harvested area, yield, and climatic conditions of 29 kinds of Chinese herbal medicines in 2011 will be used as basic data and can be used to compare with the changes in the planting conditions of Chinese herbal medicines in subsequent years. Publishes the increase or decrease in the planting area of ​​Chinese herbal medicines and makes industrial early warning.
(a) Rhizome herbs.
There are 22 kinds of root and stem herbs in this statistics, accounting for 76% of the first batch of monitored varieties. Respectively: Ginseng, Panax Notoginseng, Rhizoma Chuanxiong, rhubarb, yam, heterophylla, Yuanhu, Salvia, Gastrodia elata, Pinellia, Angelica, Licorice, Rehmannia, Angelica, Ophiopogon japonicus, Cortex Mouttuyniae, Fuzi, Magnolia, Codonopsis, Coptis chinensis, Huang Hao, Huang Hao. The reason for taking the rhizomes as the first monitoring point is that these herbs have the characteristics of relatively long planting cycle, non-sustainable harvesting, and relatively easy to hype. In recent years, the varieties with abnormal price fluctuations are mainly rhizomes. The analysis of the planting and producing area prices of rhizomes in 2011 is represented by Panax notoginseng and Panax ginseng. See Appendix Table 1 for Other rhizome medicines.
Ginseng is mainly planted in Jilin, Heilongjiang and Liaoning provinces. According to the circulation analysis system for key varieties of Chinese herbal medicines, in 2011, the national ginseng planting area was 19,830 mu, of which 4,599 mu was harvested and the output was 2,680 tons. Due to the different ginseng's grading price, it is impossible to give an accurate price. This statistic provides the average reference price of origin, which is about 285.8 yuan/kg.
Sanqi is mainly planted in Yunnan and Guangxi. In 2011, the existing planting area of ​​Sanqi in the two provinces was 167609 mu, of which the harvested area was 4,745 mu and the yield was 475 tons. The average reference price of producing areas was approximately 276.7 yuan per kg.
(b) Flower herbs.
The statistics of the flowering medicinal materials is only a species of honeysuckle, and it is also a species with large fluctuations in price in recent years. Especially when a sudden epidemics such as influenza A and influenza are encountered, prices will rise irrationally. According to the circulation analysis system of key varieties of Chinese herbal medicines, the main producing areas of honeysuckle in Shandong, Henan, and Hebei had a planting area of ​​288,000 mu in 2011, a harvested area of ​​206,000 mu and a yield of 17,445 tons. The average reference price of producing areas is 125 yuan/kg.
(3) Chinese herbal medicines.
The statistics of the fruit category of Chinese medicinal materials include wolfberry, silymarin, hawthorn, and forsythia. Among them, wolfberry is a representative of dual-use medicinal and herbal medicines. It is important to understand the planting and harvesting conditions of wolfberry and to understand the dual-purpose Chinese herbal medicines. According to the statistical analysis system of key varieties of Chinese herbal medicines, in 2011, there were about 320,000 mu of clams planted in Ningxia and Xinjiang, of which the harvested area was about 300,000 mu and the output was about 60,000 tons. The average reference price of producing areas was 40 yuan/kg.
(d) fungus medicines.
The statistical medicine for the fungus is wolfberry. It belongs to the widely used and large amount of fungi. According to the statistical analysis system of key varieties of Chinese herbal medicines, in 2011, about 48,300 mu of acreage was planted in China, and the output was about 20,000 tons. The average reference price of producing areas was about 14.5 yuan per kg.
(e) animal medicines.
This time only included antler an animal medicine. Currently, pilose antler mainly comes from three deer deer, red deer, and New Zealand deer. Because of the concentration and statistical convenience of breeding, they are the representatives of animal medicines. According to the statistical analysis of the key varieties of Chinese herbal medicines, in 2011, there were 51,943 aquaculture deers in China. There are 39915 deer that can harvest velvet and the output is about 206 tons. The average reference price of producing areas is about 1,757 yuan/kg.
III. Circulation of 29 kinds of key Chinese herbal medicines in 2011 The status of circulation of 29 kinds of Chinese medicinal materials was analyzed using ginseng as the representative. For the circulation of other Chinese herbal medicines, see Attached Table 2. In addition to the centralized characteristics of ginseng, the ginseng is a major sales category in 17 Chinese herbal medicine specialty markets across the country, and also has its own origin market, such as the Fusong ginseng trade market in Jilin Province and the Northeast ginseng Chinese herbal medicine trade market.
According to the statistical analysis of the key varieties of Chinese herbal medicines, the national average price of ginseng products in 2011 was 365 yuan/kg, with a total purchase of 12032 tons, sales of 9022 tons, inventory of 3009 tons and sales of 4 billion yuan.
The "Report" pointed out that in response to the anomalous fluctuations in prices of Chinese herbal medicines and asymmetric production and sales information in recent years, according to the requirements of the National Drug Distribution Industry Development Outline (2011-2015), in 2012, the Ministry of Commerce established key varieties of Chinese herbal medicines. The circulation analysis system provides the government and industry with basic information on the circulation of Chinese herbal medicines and promotes the healthy development of the Chinese herbal medicine industry.
The publication of the "Report" has changed the situation of the lack of authoritative statistical information on the circulation of Chinese herbal medicines for a long time. It is of great significance to maintain the basic stability of Chinese herbal medicines, effectively guide production and sales, and formulate policies for the development of Chinese herbal medicine industry.
According to the progress of this work, the Ministry of Commerce will gradually increase statistical varieties and expand market coverage so that circulation analysis of key varieties of Chinese herbal medicines can fully reflect the dynamics of Chinese herbal medicines circulation.
Analysis report on the circulation of some key varieties of Chinese herbal medicines in 2011 The Chinese herbal medicines are the basis of the Chinese medicine industry. The circulation of Chinese herbal medicines is an important part of the circulation of medicines. In response to the anomalous fluctuations in prices of Chinese herbal medicines and asymmetric production and sales information in recent years, according to the National Outline for the Development of Drug Distribution Industry (2011-2015), in 2012, the Ministry of Commerce established a circulation analysis system for key varieties of Chinese herbal medicines. Providing basic information on the circulation of Chinese herbal medicines for the government and industry, and promoting the healthy development of the Chinese herbal medicine industry.Analysis of basic market information such as cultivation, price, sales, and inventory of some key varieties of Chinese herbal medicines in 2011 has been completed, and the results are reported below.
I. The statistical varieties of key varieties of Chinese herbal medicines and circulation analysis data for the circulation analysis of key varieties of Chinese herbal medicines are gradually developed in stages. The first statistical analysis of 29 kinds of Chinese medicinal materials are: ginseng, Panax notoginseng, Rhizoma Chuanxiong, rhubarb, yam, hawthorn, milk thistle, heterophylla, Yuanhu, Salvia, gastrodia, Pinellia, Angelica, licorice, rehmannia root, angelica, wheat Winter, forsythia, moutan, aconite, honeysuckle, Chinese wolfberry, Magnolia officinalis, Poria, Codonopsis, Coptis, Astragalus, Astragalus, pilose antler. In the future, based on the progress of this work, we will gradually increase the statistical analysis of varieties, so that the circulation analysis system of key varieties of Chinese herbal medicines can reflect the situation of the entire industry as far as possible.
The statistical data of planting area and production of 29 kinds of Chinese herbal medicines come from the business and agriculture and forestry departments of 104 Chinese herbal medicine producing areas; the market circulation of Chinese herbal medicines comes from 13 professional markets of Chinese medicinal materials (see Table 3 in the attached list); there are 6 Chinese herbs The professional web site (listed in Schedule 4) participated in the supplementary reporting of relevant data.
II. Price of planting and producing areas of 29 key Chinese herbal medicines in 2011 The planting area, harvested area, yield, and climatic conditions of 29 kinds of Chinese herbal medicines in 2011 will be used as basic data and can be used to compare with the changes in the planting conditions of Chinese herbal medicines in subsequent years. Publishes the increase or decrease in the planting area of ​​Chinese herbal medicines and makes industrial early warning.
(a) Rhizome herbs.
There are 22 kinds of root and stem herbs in this statistics, accounting for 76% of the first batch of monitored varieties. Respectively: Ginseng, Panax Notoginseng, Rhizoma Chuanxiong, rhubarb, yam, heterophylla, Yuanhu, Salvia, Gastrodia elata, Pinellia, Angelica, Licorice, Rehmannia, Angelica, Ophiopogon japonicus, Cortex Mouttuyniae, Fuzi, Magnolia, Codonopsis, Coptis chinensis, Huang Hao, Huang Hao. The reason for taking the rhizomes as the first monitoring point is that these herbs have the characteristics of relatively long planting cycle, non-sustainable harvesting, and relatively easy to hype. In recent years, the varieties with abnormal price fluctuations are mainly rhizomes. The analysis of the planting and producing area prices of rhizomes in 2011 is represented by Panax notoginseng and Panax ginseng. See Appendix Table 1 for Other rhizome medicines.
Ginseng is mainly planted in Jilin, Heilongjiang and Liaoning provinces. According to the circulation analysis system for key varieties of Chinese herbal medicines, in 2011, the national ginseng planting area was 19,830 mu, of which 4,599 mu was harvested and the output was 2,680 tons. Due to the different ginseng's grading price, it is impossible to give an accurate price. This statistic provides the average reference price of origin, which is about 285.8 yuan/kg.
Sanqi is mainly planted in Yunnan and Guangxi. In 2011, the existing planting area of ​​Sanqi in the two provinces was 167609 mu, of which the harvested area was 4,745 mu and the yield was 475 tons. The average reference price of producing areas was approximately 276.7 yuan per kg.
(b) Flower herbs.
The statistics of the flowering medicinal materials is only a species of honeysuckle, and it is also a species with large fluctuations in price in recent years. Especially when a sudden epidemics such as influenza A and influenza are encountered, prices will rise irrationally. According to the circulation analysis system of key varieties of Chinese herbal medicines, the main producing areas of honeysuckle in Shandong, Henan, and Hebei had a planting area of ​​288,000 mu in 2011, a harvested area of ​​206,000 mu and a yield of 17,445 tons. The average reference price of producing areas is 125 yuan/kg.
(3) Chinese herbal medicines.
The statistics of the fruit category of Chinese medicinal materials include wolfberry, silymarin, hawthorn, and forsythia. Among them, wolfberry is a representative of dual-use medicinal and herbal medicines. It is important to understand the planting and harvesting conditions of wolfberry and to understand the dual-purpose Chinese herbal medicines. According to the statistical analysis system of key varieties of Chinese herbal medicines, in 2011, there were about 320,000 mu of clams planted in Ningxia and Xinjiang, of which the harvested area was about 300,000 mu and the output was about 60,000 tons. The average reference price of producing areas was 40 yuan/kg.
(d) fungus medicines.
The statistical medicine for the fungus is wolfberry. It belongs to the widely used and large amount of fungi. According to the statistical analysis system of key varieties of Chinese herbal medicines, in 2011, about 48,300 mu of acreage was planted in China, and the output was about 20,000 tons. The average reference price of producing areas was about 14.5 yuan per kg.
(e) animal medicines.
This time only included antler an animal medicine. Currently, pilose antler mainly comes from three deer deer, red deer, and New Zealand deer. Because of the concentration and statistical convenience of breeding, they are the representatives of animal medicines. According to the statistical analysis of the key varieties of Chinese herbal medicines, in 2011, there were 51,943 aquaculture deers in China. There are 39915 deer that can harvest velvet and the output is about 206 tons. The average reference price of producing areas is about 1,757 yuan/kg.
III. Circulation of 29 kinds of key Chinese herbal medicines in 2011 The status of circulation of 29 kinds of Chinese medicinal materials was analyzed using ginseng as the representative. For the circulation of other Chinese herbal medicines, see Attached Table 2. In addition to the centralized characteristics of ginseng, the ginseng is a major sales category in 17 Chinese herbal medicine specialty markets across the country, and also has its own origin market, such as the Fusong ginseng trade market in Jilin Province and the Northeast ginseng Chinese herbal medicine trade market.
According to the statistical analysis of the key varieties of Chinese herbal medicines, the national average price of ginseng products in 2011 was 365 yuan/kg, with a total purchase of 12032 tons, sales of 9022 tons, inventory of 3009 tons and sales of 4 billion yuan.
We are professional manufacturer of Privacy Pop-Up Tent. We focused on international export product development, production and sales. We have improved quality control processes of Privacy Pop-Up Tent to ensure each export qualified product.
If you want to know more about the products in Privacy Pop-Up Tent, please click the product details to view parameters, models, pictures, prices and other information about Privacy Pop-Up Tent.
Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Privacy Pop-Up Tent!
Dressing Tent,Privacy Pop-Up Tent,Waterproof Tent,Portable Tent
CAREABLE BIOTECHNOLOGY CO,. LTD , https://www.careablemask.com